Issue 1/2016
Content (23 Articles)
Levetiracetam for seizure prevention in brain tumor patients: a systematic review
Ziad Ghantous Nasr, Bridget Paravattil, Kyle John Wilby
Risk and survival outcomes of radiation-induced CNS tumors
Jessica W. Lee, A. Gabriella Wernicke
Differential DNA methylome profiling of nonfunctioning pituitary adenomas suggesting tumour invasion is correlated with cell adhesion
Ye Gu, Xinyao Zhou, Fan Hu, Yong Yu, Tao Xie, Yuying Huang, Xinzhi Zhao, Xiaobiao Zhang
F8-SIP mediated targeted photodynamic therapy leads to microvascular dysfunction and reduced glioma growth
G. Acker, A. Palumbo, D. Neri, P. Vajkoczy, M. Czabanka
Quercetin blocks t-AUCB-induced autophagy by Hsp27 and Atg7 inhibition in glioblastoma cells in vitro
Junyang Li, Chao Tang, Liwen Li, Rujun Li, Youwu Fan
An allograft mouse model for the study of hearing loss secondary to vestibular schwannoma growth
Nicolas-Xavier Bonne, Jérémie Vitte, Fabrice Chareyre, Gevorg Karapetyan, Vazgen Khankaldyyan, Karo Tanaka, Rex A. Moats, Marco Giovannini
Treatment with the PI3K inhibitor buparlisib (NVP-BKM120) suppresses the growth of established patient-derived GBM xenografts and prolongs survival in nude rats
I. A. Netland, H. E. Førde, L. Sleire, L. Leiss, M. A. Rahman, B. S. Skeie, H. Miletic, P. Ø. Enger, D. Goplen
Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation
Magdalena Ciezka, Milena Acosta, Cristina Herranz, Josep M. Canals, Martí Pumarola, Ana Paula Candiota, Carles Arús
Serial cerebrospinal fluid examinations to diagnose hematological malignancy causing neurological disease
Eugene L. Scharf, Curtis A. Hanson, Matthew T. Howard, B. Mark Keegan
Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series
J. Castelli, L. Feuvret, Q. C. Haoming, J. Biau, E. Jouglar, A. Berger, G. Truc, F. Llamas Gutierrez, X. Morandi, P. J. Le Reste, F. Thillays, D. Loussouarn, E. Nouhaud, G. Crehange, D. Antoni, E. Vauleon, R. de Crevoisier, G. Noel
Prognostic factors in recurrent glioblastoma patients treated with bevacizumab
Christina Schaub, Julia Tichy, Niklas Schäfer, Kea Franz, Frederic Mack, Michel Mittelbronn, Sied Kebir, Anna-Luisa Thiepold, Andreas Waha, Natalie Filmann, Mohammed Banat, Rolf Fimmers, Joachim P. Steinbach, Ulrich Herrlinger, Johannes Rieger, Martin Glas, Oliver Bähr
Transforming growth factor-β and stem cell markers are highly expressed around necrotic areas in glioblastoma
Yasuo Iwadate, Tomoo Matsutani, Seiichiro Hirono, Natsuki Shinozaki, Naokatsu Saeki
Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma
Fernando Carceller, Lucy A. Fowkes, Komel Khabra, Lucas Moreno, Frank Saran, Anna Burford, Alan Mackay, David T. W. Jones, Volker Hovestadt, Lynley V. Marshall, Sucheta Vaidya, Henry Mandeville, Neil Jerome, Leslie R. Bridges, Ross Laxton, Safa Al-Sarraj, Stefan M. Pfister, Martin O. Leach, Andrew D. J. Pearson, Chris Jones, Dow-Mu Koh, Stergios Zacharoulis
Prevalence and profile of cognitive impairment in adult glioma: a sensitivity analysis
Mathieu Boone, Martine Roussel, Bruno Chauffert, Daniel Le Gars, Olivier Godefroy
Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study
Regina I. Jakacki, Margaret A. Foley, Julie Horan, Jiuzhou Wang, Mark W. Kieran, Daniel C. Bowers, Eric Bouffet, Stergios Zacharoulis, Stan C. Gill
A phase II trial evaluating the effects and intra-tumoral penetration of bortezomib in patients with recurrent malignant gliomas
Jeffrey J. Raizer, James P. Chandler, Roberto Ferrarese, Sean A. Grimm, Robert M. Levy, Kenji Muro, Joshua Rosenow, Irene Helenowski, Alfred Rademaker, Martin Paton, Markus Bredel
Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma
Jacob J. Mandel, David Cachia, Diane Liu, Charmaine Wilson, Ken Aldape, Greg Fuller, John F. de Groot
Coping with a newly diagnosed high-grade glioma: patient-caregiver dyad effects on quality of life
K. Baumstarck, T. Leroy, Z. Hamidou, E. Tabouret, P. Farina, M. Barrié, C. Campello, G. Petrirena, O. Chinot, P. Auquier
Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma
Felicitas Strehlow, Sandra Bauer, Peter Martus, Michael Weller, Patrick Roth, Uwe Schlegel, Sabine Seidel, Carmen Scheibenbogen, Agnieszka Korfel, Stephan Kreher
Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1
Michael J. Wan, Nicole J. Ullrich, Peter E. Manley, Mark W. Kieran, Liliana C. Goumnerova, Gena Heidary
Antidepressant use and risk of central nervous system metastasis
Megan M. Herr, Nimish A. Mohile, Edwin van Wijngaarden, Edward B. Brown, David Q. Rich
Comment on: Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients?
André O. von Bueren, Clemens Seidel, Carsten Friedrich
First report on spinal metastasis in childhood-onset craniopharyngioma
Anika Hoffmann, Angela Brentrup, Hermann L. Müller